Home › Therapeutic areas › Ophthalmology › Diabetic Macular Edema
Diabetic Macular Edema (6 companies)
Companies with an active program in Diabetic Macular Edema.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics | OphthalmologyRespiratory Rare | 1 | Phase 3 | $677M | 5 |
| BIOA | BioAge Labs | CardiovascularOphthalmology | 1 | Phase 2 | $245M | 2 |
| EYPT | EyePoint | Ophthalmology | 1 | Phase 3 | $31.0M | 2 |
| KOD | Kodiak Sciences | Ophthalmology | 1 | Phase 3 | $6.24B | 8 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 1 | Phase 3 | $314M | 12 |
| OTLK | Outlook Therapeutics | Ophthalmology | 1 | Approved | $106M | 3 |
No companies match.